Skip to main content
FDA Updates
Reversible Posterior Leukoencephalopathy Syndrome Secondary to Bevacizumab
Diana Pinto, PharmD, William Kernan, PharmD, BCPS, James Hoffman, MD, Mohammed Ibrahim, PharmD, CRPH, BCOP, BCPS, Bruno Bastos, MD
Read More
Original Research
The Risk of Neurotoxicity with Concomitant Use of Aprepitant and Ifosfamide
Anthony Jarkowski III, PharmD, BCOP, Austin Miller, PhD, Tammy A. Hecke, RN, BSN, Leona Blustein, PharmD, Michael K.K. Wong, MD, PhD, FRCPC
Read More
Practical Issues in Pharmacy Management
Implementation of a Pharmacist-Managed Interdisciplinary Oral Chemotherapy Program in a Community Cancer Center
Robert Mancini, PharmD, BCOP, FHOPA, Lindsay M. Kaster, PharmD, Brian Vu, PharmD, Jessie Modlin, PharmD, David B. Wilson, RPh
Read More
From the Literature
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
Read More
Online First
Exemestane: A Promising New Option for Primary Prevention of Breast Cancer
Audrey Andrews
Read More
Online First
Bevacizumab in Ovarian Cancer: More Support for Maintenance
Audrey Andrews
Read More
Online First
Novel Agents Improve Survival in Metastatic Melanoma
Audrey Andrews
Read More
Online First
PARP Inhibitor Prolongs Progression-Free Survival in Ovarian Cancer
Audrey Andrews
Read More
Online First
Supportive Care
NCCN Helps Guide Optimal Use of Myeloid Growth Factors for Prevention of Neutropenia
Audrey Andrews
Read More
Online First
Novel Prostate Brachytherapy Technique May Reduce Posttreatment Urinary Complications
John Schieszer
Read More
Page 194 of 199
Results 1931 - 1940 of 1986